USD0.000æéå€ååŒÂ  (ET)
2.03BæäŸ¡ç·é¡
10.14çŽè¿12ã¶æPER
äž»èŠããŒã¿
7.980å§å€
7.980é«å€
484.88Kåºæ¥é«
10.14çŽè¿12ã¶æPER
2.24äºæ³PER
0.137çŽè¿12ã¶æé
åœ
0.19%売買å転ç
8.200忥çµå€
7.710å®å€
2.65M売買代é
11.97æ ªäŸ¡åçç
0.33PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
1.74%çŽè¿12ã¶æé
åœå©åã
2.48%ç·è³ç£å©çç
11.14052é±é«å€
0.47åºæ¥é«æ¯ç%
169.72MçŽå©ç
258.22Mæ ªåŒæ°
0.77601æ ªåœããå©çïŒEPSïŒ
0.66ããŒã¿å€
7.67%èªå·±è³æ¬å©çç
7.39052é±å®å€
3.29%æ¯ãå¹
36.47%ç²å©çç
2.03BæäŸ¡ç·é¡
9.27ãªã¹ã¯ãªã¿ãŒã³
1.55%ãªã¹ã¯ç
é貚: USD æŽæ°æå»: 2026-07-31 äž»èŠã€ã³ãµã€ã
Grifols SAã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçå®å®ã§ããæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸããå»è¬åæ¥çã§ã®é äœã¯155äž48äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããè²·ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯11.73ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯å®å®æšç§»ãšäºæ³ãããŸããéå»1ãæã®æ ªåŒåžå Žã®ããã©ãŒãã³ã¹ã¯è¯å¥œã§ããã¡ã³ãã¡ã³ã¿ã«ãºãåªããŠããŸãããããã¯ãã«ã«ã¯çŸåšã®ãã¬ã³ããè£ä»ãããã®ã§ã¯ãããŸãããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Grifols SAã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
Grifols SAã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
Grifols SA ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
åçäºæž¬î
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
ææšî
ææš
売ã(3)
äžç«(2)
è²·ã(2)
ç§»åå¹³å
売ã(2)
äžç«(0)
è²·ã(4)
è²¡åææšî
EPS

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Grifols SAã®äŒæ¥æ
å ±î
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
äŒæ¥ã³ãŒãGRFS
äŒæ¥åGrifols SA
æé«çµå¶è²¬ä»»è
ãCEOãAbia (Jose Ignacio)
ãŠã§ããµã€ãhttps://www.grifols.com/
æ ªäž»çµ±èšî
ãããã質å
Grifols SAïŒGRFSïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îGrifols SAïŒGRFSïŒã®çŸåšã®æ ªäŸ¡ã¯7.88ã§ãã
Grifols SAã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îGrifols SAã®ãã£ãã«ãŒã·ã³ãã«ã¯GRFSã§ãã
Grifols SAã®52é±é«å€ã¯ãããã§ããïŒ
îGrifols SAã®52é±é«å€ã¯11.14ã§ãã
Grifols SAã®52é±å®å€ã¯ãããã§ããïŒ
îGrifols SAã®52é±å®å€ã¯7.39ã§ãã
Grifols SAã®æäŸ¡ç·é¡ã¯ãããã§ããïŒ
îGrifols SAã®æäŸ¡ç·é¡ã¯2.03Bã§ãã
Grifols SA (GRFS) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãGrifols SAïŒGRFSïŒã®ç·åè©äŸ¡ã¯è²·ãã§ãç®æšæ ªäŸ¡ã¯11.73ã§ãã
Grifols SA (GRFS) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îGrifols SAïŒGRFSïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯0.67ã§ãã